University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2016–2021 · cooperative agreement · U54

The CSBC Research Center for Cancer Systems Immunology at MSKCC

Christina S Leslie · Kettering University · funded by National Institutes of Health

$2.1MCancer Immunotherapy and Biomarkers

2016–2021 · research · R01

Developmental studies to inform clinical stratification and targeting of SHH MB

Alexandra L. Joyner · Kettering University · funded by National Institutes of Health

$452.8k

2016–2019 · research · R01

A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use

Balu Easwaramoorthy · Kettering University · funded by National Institutes of Health

$555.7kRadiopharmaceutical Chemistry and Applications

2016–2020 · research · R01

Dose-distribution radiomics to predict morbidity risk in radiotherapy

Joseph O Deasy · Kettering University · funded by National Institutes of Health

$577.3kRadiomics and Machine Learning in Medical Imaging

2016–2023 · research · R35

Studies on oncoprotein-induced feedback: Basic and therapeutic implications

Neal Rosen · Kettering University · funded by National Institutes of Health

$1.1M

2016–2018 · research · R21

Exploring function of mu opioid receptor splice variants in rat by gene targeting

Ying-Xian Pan · Kettering University · funded by National Institutes of Health

$257.1kNeuropeptides and Animal Physiology

2016–2021 · research · R35

Structural studies of RNA processing and ubiquitin-like protein modification

Christopher D. Lima · Kettering University · funded by National Institutes of Health

$439.8kRNA modifications and cancer

2016–2021 · research · R01

Exploring oncogenic translation programs in cancer

Hans-Guido Wendel · Kettering University · funded by National Institutes of Health

$426.1kPI3K/AKT/mTOR signaling in cancer

2016–2023 · research · R35

Studies on oncoprotein-induced feedback: Basic and therapeutic implications

Neal Rosen · Kettering University · funded by National Institutes of Health

$1.1M

2016–2021 · research · R01

Comprehensive genetic dissection of druggable KRAS targets

Steven D Leach · Kettering University · funded by National Institutes of Health

$392.1k

2016–2026 · research · R35

Mechanism and regulation of meiotic recombination

Scott Keeney · Kettering University · funded by National Institutes of Health

$463.6kDNA Repair Mechanisms

2016–2022 · cooperative agreement · U54

The CSBC Research Center for Cancer Systems Immunology at MSKCC

Christina S Leslie · Kettering University · funded by National Institutes of Health

$2.3M

2016–2020 · research · R01

Study of exposures and biomarkers in cancer epidemiology

Jaya M Satagopan · Kettering University · funded by National Institutes of Health

$397.5k

2016–2018 · research · R21

Sphingolipid-Based Anti-Angiogenic Chemosensitization

Richard N Kolesnick · Kettering University · funded by National Institutes of Health

$223.7kSphingolipid Metabolism and Signaling

2016–2021 · grant · DP1

3'UTR-mediated protein-protein interactions determine protein functions

Christine Mayr · Kettering University · funded by National Institutes of Health

$1.2M

2016–2020 · research · R01

Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma

Katharine C Hsu · Kettering University · funded by U.S. Food and Drug Administration

$249.9k

2016–2021 · research · R01

Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy

Thomas Reiner · Kettering University · funded by National Institutes of Health

$506.9k

2016–2021 · research · R01

Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy

Thomas Reiner · Kettering University · funded by National Institutes of Health

$515.2k

2016–2021 · program · P50

MSK SPORE in Lymphoma

Anas Younes · Kettering University · funded by National Institutes of Health

$2.3M

2016–2021 · career development · K08

Analysis of TET2 function in acute leukemia

Alan Shih · Kettering University · funded by National Institutes of Health

$180kAcute Myeloid Leukemia Research

2016–2021 · research · R01

Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance

Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health

$511.6kHistiocytic Disorders and Treatments

2016–2021 · research · R35

Mechanism and regulation of meiotic recombination

Scott Keeney · Kettering University · funded by National Institutes of Health

$435.9kDNA Repair Mechanisms

2016–2019 · cooperative agreement · U01

Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer

James L. Gulley · Kettering University · funded by National Institutes of Health

$470.5kImmunotherapy and Immune Responses

2016–2021 · research · R01

MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS

Lorenz P. Studer · Kettering University · funded by National Institutes of Health

$598.1kCongenital gastrointestinal and neural anomalies

2016–2019 · fellowship · F32

Development of 18F-based Pretargeted PET imaging strategies for the PET imaging of cancer

Jan-Philip Meyer · Kettering University · funded by National Institutes of Health

$54.3k

2016–2018 · research · R03

Investigation of the Effects of Electronic Cigarettes on Vascular Health

Roman Shingarev · Kettering University · funded by National Institutes of Health

$128.6kSmoking Behavior and Cessation

2016–2021 · research · R01

Exploring oncogenic translation programs in cancer

Hans-Guido Wendel · Kettering University · funded by National Institutes of Health

$413.3kPI3K/AKT/mTOR signaling in cancer

2016–2021 · cooperative agreement · U54

The CSBC Research Center for Cancer Systems Immunology at MSKCC

Christina S Leslie · Kettering University · funded by National Institutes of Health

$2.3M

2016–2021 · program · P50

MSK SPORE in Lymphoma

Anas Younes · Kettering University · funded by National Institutes of Health

$2.3MLymphoma Diagnosis and Treatment

2016–2022 · research · R01

The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations

Craig B Thompson · Kettering University · funded by National Institutes of Health

$347kPI3K/AKT/mTOR signaling in cancer

2016–2021 · research · R01

KIR and HLA in cis and trans cooperatively shape human NK education

Katharine C Hsu · Kettering University · funded by National Institutes of Health

$428.5kImmune Cell Function and Interaction

2016–2023 · research · R35

Studies on oncoprotein-induced feedback: Basic and therapeutic implications

Neal Rosen · Kettering University · funded by National Institutes of Health

$1M

2016–2021 · cooperative agreement · U01

Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens

Eric G. Pamer · Kettering University · funded by National Institutes of Health

$1.7M

2016–2021 · research · R01

Determinants of acquired resistance in small cell lung cancer

Charles M. Rudin · Kettering University · funded by National Institutes of Health

$615.6kLung Cancer Research Studies

2016–2021 · research · R35

Homologous recombination mechanisms in mammalian cells

Maria Jasin · Kettering University · funded by National Institutes of Health

$531.4kDNA Repair Mechanisms

2016–2021 · cooperative agreement · U01

Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant Pathogens

Eric G. Pamer · Kettering University · funded by National Institutes of Health

$2M

2016–2019 · research · R21

Novel antitrypanosomal alkaloids for Chagas disease

James H. Mckerrow · Kettering University · funded by National Institutes of Health

$244.8kTrypanosoma species research and implications

2016–2020 · research · R01

Dose-distribution radiomics to predict morbidity risk in radiotherapy

Joseph O Deasy · Kettering University · funded by National Institutes of Health

$577.8kRadiomics and Machine Learning in Medical Imaging

2016–2022 · research · R01

Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer Screening

Jamie S. Ostroff · Kettering University · funded by National Institutes of Health

$180.4k

2016–2020 · research · R01

Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma

Katharine C Hsu · Kettering University · funded by U.S. Food and Drug Administration

$249.8k